Key result
Depression and anxiety affect up to ~30% of AF patients and correlate with quality of life.
Why the study?
Depression and anxiety may influence the effectiveness of cardioversion and ablation in patients with AF and/or atrial flutter, but knowledge regarding these symptoms at the time of procedures is lacking.
Population
171 patients with AF at the time of cardioversion or ablation
Design
Observational cohort study
Follow-up
6 months
Authors
Loading...
Merits screening for depression and anxiety in AF patients at cardioversion or ablation; leaves open effects on quality of life and recurrence.
Observational (n=171)
Depressive symptoms and anxiety are common in patients undergoing AF cardioversion or ablation and are associated with reduced quality of life, though not with 6-month AF recurrence.
Koleck et al. (2020) conducted an observational in Atrial fibrillation and/or flutter (n=171). Cardioversion or ablation was evaluated on Prevalence of depressive symptoms and anxiety. Depressive symptoms (17.2%) and state anxiety (30.2%) were highly prevalent among patients with atrial fibrillation at the time of cardioversion or ablation, and were associated with quality of life.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: